{"metadata": {"source": "psychonaut", "title": "Ketamine - PsychonautWiki", "description": "Ketamine (also known as Ket, K, Special K, vitamin K,[5] Kitty, and others) is a classical dissociative substance of the arylcyclohexylamine class. It is perhaps the best-known and archetypal member of the dissociatives, a diverse group which includes PCP, methoxetamine, DXM, and nitrous oxide. The mechanism of action is not fully known, although blocking of the NMDA glutamate receptor is thought to be involved.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Ketamine", "drug": "Ketamine", "cid": 3821, "char_count": 56055, "word_count": 7891, "doc_id": "doc_81", "num_chunks": 72, "chunk_id": "81::chunk_9", "document_index": 81, "latency_s": 0.7459021000104258, "prompt_toks": 14658, "completion_toks": 49, "relevance_score": 9.042455e-08}, "content": "Drug: Ketamine | cid: 3821\nSource: psychonaut | Source description: Ketamine (also known as Ket, K, Special K, vitamin K,[5] Kitty, and others) is a classical dissociative substance of the arylcyclohexylamine class. It is perhaps the best-known and archetypal member of the dissociatives, a diverse group which includes PCP, methoxetamine, DXM, and nitrous oxide. The mechanism of action is not fully known, although blocking of the NMDA glutamate receptor is thought to be involved.\n\n                    Text: \n                    Enantiomers\n\nKetamine is a mixture of equal amounts of two enantiomers: esketamine and arketamine.\n\nEsketamine is a more potent NMDA receptor antagonist and dissociative hallucinogen than arketamine.[19] Because of the hypothesis that NMDA receptor antagonism underlies the antidepressant effects of ketamine, esketamine was developed as an antidepressant.\n\nHowever, multiple other NMDA receptor antagonists, including memantine, lanicemine, rislenemdaz, rapastinel, and 4-chlorokynurenine, have thus far failed to demonstrate sufficient effectiveness for depression.[19]\n\nFurthermore, animal research indicates that arketamine, the enantiomer with a weaker NMDA receptor antagonism, as well as (2R,6R)-hydroxynorketamine, the metabolite with negligible affinity for the NMDA receptor but a potent alpha-7 nicotinic receptor antagonist may have antidepressive action.[19]\n\nPharmacology\n\nFurther information: NMDA receptor antagonist\n\n\n                    Context: \n                    This section discusses ketamine's enantiomers, esketamine and arketamine, highlighting their differing potencies and potential roles in depression treatment, and relates to its pharmacology as an NMDA receptor antagonist covered in the broader document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Ketamine - PsychonautWiki", "description": "Ketamine (also known as Ket, K, Special K, vitamin K,[5] Kitty, and others) is a classical dissociative substance of the arylcyclohexylamine class. It is perhaps the best-known and archetypal member of the dissociatives, a diverse group which includes PCP, methoxetamine, DXM, and nitrous oxide. The mechanism of action is not fully known, although blocking of the NMDA glutamate receptor is thought to be involved.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Ketamine", "drug": "Ketamine", "cid": 3821, "char_count": 56055, "word_count": 7891, "doc_id": "doc_81", "num_chunks": 72, "chunk_id": "81::chunk_18", "document_index": 81, "latency_s": 0.763241000007838, "prompt_toks": 14612, "completion_toks": 56, "relevance_score": 7.61451e-08}, "content": "Drug: Ketamine | cid: 3821\nSource: psychonaut | Source description: Ketamine (also known as Ket, K, Special K, vitamin K,[5] Kitty, and others) is a classical dissociative substance of the arylcyclohexylamine class. It is perhaps the best-known and archetypal member of the dissociatives, a diverse group which includes PCP, methoxetamine, DXM, and nitrous oxide. The mechanism of action is not fully known, although blocking of the NMDA glutamate receptor is thought to be involved.\n\n                    Text: \n                    It does not extend beyond level 4 and can be comprehensively described in its variations as: simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, large in size, fast in speed, smooth in motion, equal in rounded and angular corners, immersive in its depth and consistent in its intensity.\n\nBeyond simple geometric shape hallucinations, high doses of ketamine that enter the \"hole\" can yield a white glow and other low complexity hallucinations like ghosts of people formed of white strings.\n\nHallucinatory states\n\nHigher doses of ketamine can produce a full range of high-level hallucinatory states in a fashion that is less consistent and reproducible than that of many common psychedelics. These effects include:\n\nMachinescapes\n\n\n                    Context: \n                    This excerpt details the visual hallucinations and geometric effects produced by ketamine, including their characteristics, complexity levels, and high-dose \"hole\" states. It is relevant for understanding ketamine's subjective visual and hallucinatory effects, contributing to harm reduction and user experience knowledge.\n                "}
{"metadata": {"source": "psychonaut", "title": "Oxycodone - PsychonautWiki", "description": "Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Oxycodone", "drug": "Oxycodone", "cid": 5284603, "char_count": 20642, "word_count": 2894, "doc_id": "doc_88", "num_chunks": 28, "chunk_id": "88::chunk_22", "document_index": 88, "latency_s": 0.5898080000042683, "prompt_toks": 5519, "completion_toks": 64, "relevance_score": 7.496458e-08}, "content": "Drug: Oxycodone | cid: 5284603\nSource: psychonaut | Source description: Oxycodone (also known under brand names including Roxicodone, OxyContin, Percocet, Oxecta, OxyIR, Endone, Oxynorm, and OxyNEO) is a semi-synthetic opioid synthesized from poppy-derived thebaine. It is a narcotic analgesic within the morphinan chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany[2][3] as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.[4]\n\n                    Text: \n                    Hong Kong: Oxycodone is regulated under Part I of Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance.[17]\n\nRussia: Oxycodone is a Schedule II controlled substance.[18]\n\nSingapore: Oxycodone is listed as a Class A drug in the Misuse of Drugs Act of Singapore, which means offences in relation to the drug attract the most severe level of punishment. A conviction for unauthorized manufacture of the drug attracts a minimum sentence of 10 years of imprisonment and corporal punishment of five strokes of the cane, and a maximum sentence of life imprisonment or 30 years of imprisonment and 15 strokes of the cane.[19] The minimum and maximum penalties for unauthorized trafficking in the drug are respectively five years of imprisonment and five strokes of the cane, and 20 years of imprisonment and 15 strokes of the cane.[20]\n\nSwitzerland: Oxycodone is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.[21]\n\n\n                    Context: \n                    This chunk provides information on the legal classification of oxycodone in various countries, including Hong Kong, Russia, Singapore, and Switzerland. It details specific regulations, controlled substance schedules, and penalties for possession, manufacture, and trafficking, complementing the overall discussion of oxycodone's legal issues within the document.\n                "}
